↓ Skip to main content

β1‐Adrenoceptor, but not β2‐adrenoceptor, subtype regulates heart rate in type 2 diabetic rats in vivo

Overview of attention for article published in Experimental Physiology, June 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
2 news outlets
facebook
3 Facebook pages

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
β1‐Adrenoceptor, but not β2‐adrenoceptor, subtype regulates heart rate in type 2 diabetic rats in vivo
Published in
Experimental Physiology, June 2017
DOI 10.1113/ep086293
Pubmed ID
Authors
Abstract

β-Adrenoceptor blockers are widely used to reduce heart rate, the strongest predictor of mortality in cardiac patients, but are less effective in diabetic patients. This study aimed to determine the specific β1 - and β2 -adrenoceptor subtype contributions to chronotropic responses in type 2 diabetes in vivo, which are currently unknown. Type 2 diabetic and non-diabetic rats were implanted with radio-telemeters to measure arterial blood pressure and derive heart rate under conscious conditions. Vascular access ports were implanted to inject isoproterenol (β1 - and β2 -adrenoceptor agonist, 0.1-300 μg kg(-1) ) in the presence of atenolol (β1 -adrenoceptor antagonist, 2000 μg kg(-1) ) or nadolol (β1 - and β2 -adrenoceptor agonist, 4000 μg kg(-1) ) to determine β-adrenoceptor subtype chronotropic contributions. Resting heart rate was reduced in diabetic rats (388 ± 62 vs. 290 ± 37 bpm non-diabetic vs. diabetic, P < 0.05, mean ± SD), which remained after atenolol or nadolol administration. Overall β-adrenoceptor chronotropic responsiveness was increased in diabetic rats (Δ heart rate at highest dose isoproterenol: 135 ± 66 vs. 205 ± 28 bpm, non-diabetic vs. diabetic, P < 0.05), a difference that diminished after β1 -adrenoceptor blockade with atenolol (Δ heart rate at highest dose isoproterenol: 205 ± 37 vs. 195 ± 22 bpm, non-diabetic vs. diabetic, P < 0.05). The β1 -adrenoceptor is the main subtype to modulate chronotropic β-adrenoceptor responses in healthy, as well as diabetic rats. This study provides novel insights in the understanding of the pathological basis of dysregulation of heart rate in type 2 diabetes, which could be important for improving the current therapeutic strategies targeting the diabetic chronotropic incompetence. This article is protected by copyright. All rights reserved.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 4 18%
Other 3 14%
Student > Bachelor 3 14%
Student > Doctoral Student 1 5%
Student > Master 1 5%
Other 0 0%
Unknown 10 45%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 5 23%
Medicine and Dentistry 3 14%
Biochemistry, Genetics and Molecular Biology 1 5%
Nursing and Health Professions 1 5%
Sports and Recreations 1 5%
Other 1 5%
Unknown 10 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 June 2017.
All research outputs
#2,648,970
of 27,788,362 outputs
Outputs from Experimental Physiology
#107
of 1,130 outputs
Outputs of similar age
#44,340
of 338,394 outputs
Outputs of similar age from Experimental Physiology
#2
of 15 outputs
Altmetric has tracked 27,788,362 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,130 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.7. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 338,394 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.